Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Insight Molecular Diagnostics Inc.Listing unverified | Sell | $5.1M | SEC | ||
Insight Molecular Diagnostics Inc.Listing unverified | Sell | $6.6M | SEC | ||
Insight Molecular Diagnostics Inc.Listing unverified | Sell | $4.5M | SEC | ||
Asterias Biotherapeutics, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
Asterias Biotherapeutics, Inc.Listing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Asterias Biotherapeutics, Inc.Listing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Asterias Biotherapeutics, Inc.Listing unverified | Other | $50.9M | SEC |